These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 22686715)

  • 1. Recent advances in the diagnosis and treatment of kala-azar.
    Sundar S; Chakravarty J
    Natl Med J India; 2012; 25(2):85-9. PubMed ID: 22686715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of rK39 for diagnosis of post kala-azar dermal leishmaniasis in Nepal.
    Das ML; Deb M; Karki BM; Sarif M; Khanal B; Bhattacharya SK; Agrawal S; Koirala S
    Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):619-25. PubMed ID: 17882997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential of direct agglutination test based on promastigote and amastigote antigens for serodiagnosis of post-kala-azar dermal leishmaniasis.
    Singh R; Subba Raju BV; Jain RK; Salotra P
    Clin Diagn Lab Immunol; 2005 Oct; 12(10):1191-4. PubMed ID: 16210482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relevance of direct agglutination test in seroepidemiological survey of Kala-azar in epidemic foci of Bihar.
    Sharma MC; Bimal S; Ranjan A; Das VN; Gupta AK; Kumar N; Kar SK
    J Commun Dis; 2000 Jun; 32(2):117-22. PubMed ID: 11198396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of an improved method for the recombinant k 39 enzyme-linked immunosorbent assay to detect visceral leishmaniasis disease and infection in Bangladesh.
    Kurkjian KM; Vaz LE; Haque R; Cetre-Sossah C; Akhter S; Roy S; Steurer F; Amann J; Ali M; Chowdhury R; Wagatsuma Y; Williamson J; Crawford S; Breiman RF; Maguire JH; Bern C; Secor WE
    Clin Diagn Lab Immunol; 2005 Dec; 12(12):1410-5. PubMed ID: 16339064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunochromatographic rK39 strip test in the serodiagnosis of visceral leishmaniasis in Tunisia.
    Saghrouni F; Gaïed-Meksi S; Fathallah A; Amri F; Ach H; Guizani I; Ben Saïd M
    Trans R Soc Trop Med Hyg; 2009 Dec; 103(12):1273-8. PubMed ID: 19070876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and serological markers of Leishmania donovani infection in healthy individuals from endemic areas of Bihar, India.
    Srivastava P; Gidwani K; Picado A; Van der Auwera G; Tiwary P; Ostyn B; Dujardin JC; Boelaert M; Sundar S
    Trop Med Int Health; 2013 May; 18(5):548-54. PubMed ID: 23464581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elimination of Kala-Azar from the Southeast Asia Region.
    Bhattacharya SK; Dash AP
    Am J Trop Med Hyg; 2017 Apr; 96(4):802-804. PubMed ID: 28115678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of direct agglutination test, rk39 Test, and ELISA for the diagnosis of visceral leishmaniasis.
    Mandal J; Khurana S; Dubey ML; Bhatia P; Varma N; Malla N
    Am J Trop Med Hyg; 2008 Jul; 79(1):76-8. PubMed ID: 18606766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can visceral leishmaniasis be eliminated from Asia?
    Joshi A; Narain JP; Prasittisuk C; Bhatia R; Hashim G; Jorge A; Banjara M; Kroeger A
    J Vector Borne Dis; 2008 Jun; 45(2):105-11. PubMed ID: 18592839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orally effective drugs for kala-azar (visceral leishmaniasis): focus on miltefosine and sitamaquine.
    Sangraula H; Sharma KK; Rijal S; Dwivedi S; Koirala S
    J Assoc Physicians India; 2003 Jul; 51():686-90. PubMed ID: 14621038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PCR and direct agglutination as Leishmania infection markers among healthy Nepalese subjects living in areas endemic for Kala-Azar.
    Bhattarai NR; Van der Auwera G; Khanal B; De Doncker S; Rijal S; Das ML; Uranw S; Ostyn B; Praet N; Speybroeck N; Picado A; Davies C; Boelaert M; Dujardin JC
    Trop Med Int Health; 2009 Apr; 14(4):404-11. PubMed ID: 19228350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of the recombinant K39 dipstick test and the direct agglutination test in a setting endemic for visceral leishmaniasis in Nepal.
    Bern C; Jha SN; Joshi AB; Thakur GD; Bista MB
    Am J Trop Med Hyg; 2000; 63(3-4):153-7. PubMed ID: 11388508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Qualitative and semi-quantitative comparison of an rK39 strip test and direct agglutination test for detection of anti-Leishmania donovani antibodies in the Sudan.
    Mansour D; Abass EM; Mahamoud A; el Harith A
    Iran J Immunol; 2009 Dec; 6(4):208-15. PubMed ID: 20054109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accurate Serodetection of Asymptomatic Leishmania donovani Infection by Use of Defined Antigens.
    Vallur AC; Reinhart C; Mohamath R; Goto Y; Ghosh P; Mondal D; Duthie MS; Reed SG
    J Clin Microbiol; 2016 Apr; 54(4):1025-30. PubMed ID: 26842701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the direct agglutination test based on freeze-dried Leishmania donovani promastigotes for the serodiagnosis of visceral leishmaniasis in Sudanese patients.
    Abdallah KA; Nour BY; Schallig HD; Mergani A; Hamid Z; Elkarim AA; Saeed OK; Mohamadani AA
    Trop Med Int Health; 2004 Oct; 9(10):1127-31. PubMed ID: 15482407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatial analysis of Leishmania donovani exposure in humans and domestic animals in a recent kala azar focus in Nepal.
    Khanal B; Picado A; Bhattarai NR; Van Der Auwera G; Das ML; Ostyn B; Davies CR; Boelaert M; Dujardin JC; Rijal S
    Parasitology; 2010 Sep; 137(11):1597-603. PubMed ID: 20459877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in Bihar, India.
    Sinha PK; van Griensven J; Pandey K; Kumar N; Verma N; Mahajan R; Kumar P; Kumar R; Das P; Mitra G; Flevaud L; Ferreyra C; Remartinez D; Pece M; Palma PP
    Clin Infect Dis; 2011 Oct; 53(7):e91-8. PubMed ID: 21890763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visceral leishmaniasis (kala-azar): challenges ahead.
    Singh RK; Pandey HP; Sundar S
    Indian J Med Res; 2006 Mar; 123(3):331-44. PubMed ID: 16778314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-Kala-Azar dermal leishmaniasis in an HIV-1-infected woman: recovery after amphotericin B following failure of oral miltefosine.
    Guffanti M; Gaiera G; Bossolasco S; Ceserani N; Ratti D; Cinque P; Salmaso F; Gianotti N; Lazzarin A
    Am J Trop Med Hyg; 2008 Nov; 79(5):715-8. PubMed ID: 18981510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.